Product image of Glucosado Braun (Glucose Monohydrate) supplied by GNH India

Glucosado Braun

Active Ingredient:
Glucose Monohydrate
Origin:
EU

Glucosado Braun (Glucose Monohydrate)

Glucosado Braun is a sterile aqueous solution for injection that contains glucose monohydrate as its active ingredient. The product is supplied in an unspecified strength and is intended for intravenous administration. It is classified as a parenteral carbohydrate used in the European Union market for medical purposes under prescription. Glucosado Braun provides exogenous glucose to support cellular energy metabolism and to help maintain plasma glucose levels.

Manufacturer / TM Owner

B. Braun Medical Lda.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucosado Braun is employed in clinical settings where rapid glucose supplementation or fluid replacement is required.

  • Treatment of acute hypoglycemia when oral intake is not feasible.
  • Component of parenteral nutrition regimens for patients unable to receive enteral feeding.
  • Fluid and electrolyte replacement in perioperative or critical‑care environments.
  • Support of carbohydrate needs during prolonged fasting or surgical procedures.
  • Maintenance of plasma glucose concentration in patients receiving insulin therapy.

Side Effects

Adverse reactions to Glucosado Braun are generally related to the intravenous administration of a carbohydrate solution.

Common

  • Mild hyperglycemia, especially when administered in large volumes.
  • Local irritation or pain at the injection site.
  • Nausea or transient vomiting.
  • Electrolyte imbalance such as mild hyponatremia.

Serious

  • Severe hyperglycemia leading to osmotic diuresis.
  • Allergic or anaphylactic reaction manifested by rash, itching, or respiratory distress.
  • Volume overload causing pulmonary edema in patients with compromised cardiac function.

Precautions & Warnings

When using Glucosado Braun, clinicians should observe several precautions to minimize risks and ensure appropriate therapy.

  • Assess blood glucose levels before and during infusion to avoid excessive hyperglycemia.
  • Adjust infusion rate in patients with renal or hepatic impairment.
  • Monitor fluid balance closely in individuals at risk for volume overload.
  • Use caution in patients with known hypersensitivity to glucose solutions.
  • Avoid rapid administration in neonates and infants due to metabolic instability.
  • Review electrolyte status, particularly sodium and potassium, before initiating therapy.

Avoid Interactions

Glucosado Braun may interact with other agents that affect glucose metabolism or fluid balance.

Avoid

  • Concurrent high‑dose insulin therapy without glucose monitoring.
  • Co‑administration with other hyperosmolar dextrose solutions.
  • Use with catecholamine infusions that can increase glucose production without adequate monitoring.

Use with caution

  • Concurrent diuretics that may exacerbate electrolyte shifts.
  • Vasopressor agents in patients with compromised cardiac function.
  • Parenteral nutrition mixtures containing other carbohydrates; adjust total carbohydrate load.

Frequently Asked Questions

Glucosado Braun contains glucose monohydrate as its sole active pharmaceutical ingredient.

It is commonly used for acute hypoglycemia, as part of parenteral nutrition, for fluid and electrolyte replacement, and to support patients during perioperative periods.

The product is supplied as a sterile aqueous solution for intravenous injection.

Use in neonates and infants should be cautious and generally limited to situations where metabolic stability can be closely monitored.

Blood glucose levels, fluid balance, and electrolyte status should be regularly assessed throughout the infusion.

No, Glucosado Braun is a prescription‑only medication in the European Union.

Common adverse effects include mild hyperglycemia, local injection site irritation, nausea, and minor electrolyte disturbances.

Severe hyperglycemia, anaphylactic reactions, and signs of volume overload such as pulmonary edema should be treated as emergencies.

Concurrent high‑dose insulin without appropriate glucose monitoring should be avoided to prevent excessive hypoglycemia or hyperglycemia.

It provides a readily available source of carbohydrate, contributing to the caloric and glucose requirements of patients who cannot receive enteral feeding.

The ATC code for Glucosado Braun is B05BB01, indicating a carbohydrate (parenteral) product.

The solution should be stored according to the manufacturer’s instructions, typically in a controlled temperature environment and protected from light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.